Walter E. DeWolf

3.4k total citations
50 papers, 1.9k citations indexed

About

Walter E. DeWolf is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Walter E. DeWolf has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 10 papers in Organic Chemistry and 9 papers in Physiology. Recurrent topics in Walter E. DeWolf's work include Antimicrobial agents and applications (6 papers), Antimicrobial Peptides and Activities (6 papers) and Biochemical Acid Research Studies (6 papers). Walter E. DeWolf is often cited by papers focused on Antimicrobial agents and applications (6 papers), Antimicrobial Peptides and Activities (6 papers) and Biochemical Acid Research Studies (6 papers). Walter E. DeWolf collaborates with scholars based in United States, United Kingdom and Russia. Walter E. DeWolf's co-authors include Lawrence I. Kruse, Paul M. Keller, David Payne, Paula J. Goodhart, Vern L. Schramm, Terrance Moore, Stephen Rittenhouse, Dennis Lee, William F. Huffman and Cheryl A. Janson and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

In The Last Decade

Walter E. DeWolf

50 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Walter E. DeWolf United States 26 984 620 190 163 147 50 1.9k
Tao Jiang China 27 1.2k 1.2× 650 1.0× 88 0.5× 370 2.3× 218 1.5× 167 2.5k
Michael Brands Germany 20 1.1k 1.1× 601 1.0× 86 0.5× 360 2.2× 353 2.4× 46 2.1k
Michael J. Stocks United Kingdom 23 800 0.8× 698 1.1× 67 0.4× 182 1.1× 109 0.7× 81 1.6k
Éric Marsault Canada 27 1.3k 1.3× 800 1.3× 109 0.6× 198 1.2× 704 4.8× 81 2.7k
William G. Gutheil United States 21 887 0.9× 190 0.3× 84 0.4× 413 2.5× 117 0.8× 65 1.7k
Anil Vasudevan United States 28 1.1k 1.1× 697 1.1× 39 0.2× 176 1.1× 59 0.4× 67 1.9k
Khalid Islam Italy 28 1.3k 1.3× 339 0.5× 33 0.2× 227 1.4× 233 1.6× 72 2.4k
Marina Pinheiro Portugal 25 755 0.8× 123 0.2× 105 0.6× 141 0.9× 134 0.9× 62 2.1k
Terry W. Moore United States 23 1.0k 1.0× 402 0.6× 49 0.3× 142 0.9× 94 0.6× 61 1.6k
Gilbert Arthur Canada 24 1.1k 1.1× 272 0.4× 91 0.5× 119 0.7× 115 0.8× 102 1.7k

Countries citing papers authored by Walter E. DeWolf

Since Specialization
Citations

This map shows the geographic impact of Walter E. DeWolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter E. DeWolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter E. DeWolf more than expected).

Fields of papers citing papers by Walter E. DeWolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter E. DeWolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter E. DeWolf. The network helps show where Walter E. DeWolf may publish in the future.

Co-authorship network of co-authors of Walter E. DeWolf

This figure shows the co-authorship network connecting the top 25 collaborators of Walter E. DeWolf. A scholar is included among the top collaborators of Walter E. DeWolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter E. DeWolf. Walter E. DeWolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hinklin, Ronald J., Brian R. Baer, Steven A. Boyd, et al.. (2019). Discovery and preclinical development of AR453588 as an anti-diabetic glucokinase activator. Bioorganic & Medicinal Chemistry. 28(1). 115232–115232. 10 indexed citations
2.
Lü, Min, Pingping Li, Gautam Bandyopadhyay, et al.. (2014). Characterization of a Novel Glucokinase Activator in Rat and Mouse Models. PLoS ONE. 9(2). e88431–e88431. 16 indexed citations
3.
Woessner, Richard, Brian Tunquist, Christine Lemieux, et al.. (2009). ARRY-520, a novel KSP inhibitor with potent activity in hematological and taxane-resistant tumor models.. PubMed. 29(11). 4373–80. 51 indexed citations
4.
Demin, Oleg, David L. Earnshaw, Frank Tobin, et al.. (2006). The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high‐throughput screening. Biotechnology and Bioengineering. 95(4). 560–571. 17 indexed citations
5.
Head, Martha S., Margret Ryan, Dennis Lee, et al.. (2001). Structure-based combinatorial library design: Discovery of non-peptidic inhibitors of caspases 3 and 8. Journal of Computer-Aided Molecular Design. 15(12). 1105–1117. 3 indexed citations
6.
Seefeld, Mark A., William H. Miller, Kenneth A. Newlander, et al.. (2001). Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. Bioorganic & Medicinal Chemistry Letters. 11(17). 2241–2244. 52 indexed citations
7.
Keller, Paul M., Mark Nuttall, Kristine Kikly, et al.. (2001). Role of caspases in human renal proximal tubular epithelial cell apoptosis. European Journal of Pharmacology. 433(2-3). 135–140. 13 indexed citations
8.
Heerding, Dirk A., George Chan, Walter E. DeWolf, et al.. (2001). 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 11(16). 2061–2065. 110 indexed citations
9.
DeWolf, Walter E. & Irwin H. Segel. (2000). Simplified Velocity Equations for Characterizing the Partial Inhibition or Nonessential Activation of Bireactant Enzymes. Journal of enzyme inhibition. 15(4). 311–333. 2 indexed citations
10.
Nuttall, Mark, Daniel P. Nadeau, Paul W. Fisher, et al.. (2000). Inhibition of caspase‐3‐like activity prevents apoptosis while retaining functionality of human chondrocytes in vitro. Journal of Orthopaedic Research®. 18(3). 356–363. 79 indexed citations
11.
Yue, Tianli, Jian Ni, Anne M. Romanic, et al.. (1999). TL1, a Novel Tumor Necrosis Factor-like Cytokine, Induces Apoptosis in Endothelial Cells. Journal of Biological Chemistry. 274(3). 1479–1486. 95 indexed citations
12.
Jacobitz, Susanne, Margret Ryan, Megan M. McLaughlin, et al.. (1997). Role of Conserved Histidines in Catalytic Activity and Inhibitor Binding of Human Recombinant Phosphodiesterase 4A. Molecular Pharmacology. 51(6). 999–1006. 20 indexed citations
13.
Keller, Paul M., et al.. (1996). Endothelin-Converting Enzyme: Substrate Specificity and Inhibition by Novel Analogs of Phosphoramidon. Biochemical and Biophysical Research Communications. 223(2). 372–378. 16 indexed citations
14.
Torphy, Theodore J., Walter E. DeWolf, David W. Green, & G P Livi. (1993). Biochemical Characteristics and Cellular Regulation of Phosphodiesterase IV. Birkhäuser Basel eBooks. 43. 51–71. 22 indexed citations
15.
DiLella, Anthony G., Nabil A. Elshourbagy, Pradip K. Bhatnagar, et al.. (1991). Expression of human preproendothelin-1 cDNA in cos cells results in the production of mature vasoactive endothelin-1. Biochemical and Biophysical Research Communications. 175(2). 697–705. 3 indexed citations
17.
DeWolf, Walter E., Steven A. Carr, Angela Varrichio, et al.. (1988). Inactivation of dopamine .beta.-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides. Biochemistry. 27(26). 9093–9101. 55 indexed citations
18.
Berkowitz, Barry A., et al.. (1988). Effects of the novel dopamine beta-hydroxylase inhibitor SK&F 102698 on catecholamines and blood pressure in spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 245(3). 850–857. 1 indexed citations
19.
Berges, David A., Walter E. DeWolf, George L. Dunn, et al.. (1986). Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate.. Journal of Biological Chemistry. 261(14). 6160–6167. 44 indexed citations
20.
DeWolf, Walter E., et al.. (1979). The catalytic site of AMP nucleosidase. Substrate specificity and pH effects with AMP and formycin 5'-PO4.. Journal of Biological Chemistry. 254(21). 10868–10875. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026